Find the latest oncology news for your sub-specialty area
The role of ctDNA, or liquid biopsy, as a predictive tool to guide and monitor…
Results from a new phase III study found that combining PD-L1 and TIGIT inhibitors plus…
The addition of durvalumab and bevacizumab to TACE significantly improved progression-free survival in patients with…
The current standard of care for identifying targetable mutations in cancer treatment is to conduct…
A new study published in the Journal of Clinical Oncology, conducted as part of the St.…
The development of any type of second cancer following CAR T cell therapy is a…
A multi-institutional study co-authored by University of Texas at Arlington (USA) scientists uncovered a mechanism…
Cancer treatments, including chemotherapy, in addition to killing a large number of tumour cells, also…
A new research paper was published in Aging and “Aging-US” by Web of Science Volume 16, Issue…
Chimeric antigen receptor T-cell therapy, or CAR T, has dramatically improved the treatment of certain…